Michelle E Melisko

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer
    Michelle E Melisko
    Breast Oncology Clinical Trials Program, UCSF Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 1710, USA
    Nat Clin Pract Oncol 6:25-33. 2009
  2. ncbi Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer
    Joseph M Letourneau
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Francisco School of Medicine, San Francisco, California, USA
    Cancer 118:1933-9. 2012
  3. ncbi Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival
    Michelle E Melisko
    Department of Medicine, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA
    J Neurooncol 88:359-65. 2008
  4. ncbi Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers
    Michelle E Melisko
    University of California, San Francisco, USA
    Clin Breast Cancer 6:45-54. 2005
  5. ncbi Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer
    John W Park
    University of California, San Francisco, San Francisco, CA 94115 1710, USA
    J Clin Oncol 25:3680-7. 2007
  6. ncbi Amelioration of sexual adverse effects in the early breast cancer patient
    Michelle E Melisko
    Department of Medicine, University of California San Francisco, 94115, USA
    J Cancer Surviv 4:247-55. 2010
  7. ncbi Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer
    Joseph M Letourneau
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco School of Medicine, San Francisco, California, USA
    Cancer 118:1710-7. 2012
  8. ncbi Brain metastases of breast cancer
    Michelle E Melisko
    Division of Hematology Oncology, University of California at San Francisco, San Francisco, CA 94115, USA
    Expert Rev Anticancer Ther 5:253-68. 2005

Detail Information

Publications8

  1. ncbi New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer
    Michelle E Melisko
    Breast Oncology Clinical Trials Program, UCSF Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115 1710, USA
    Nat Clin Pract Oncol 6:25-33. 2009
    ....
  2. ncbi Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer
    Joseph M Letourneau
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California at San Francisco School of Medicine, San Francisco, California, USA
    Cancer 118:1933-9. 2012
    ..The authors sought to describe the age-specific impact of infertility and early menopause after chemotherapy among reproductive age women with cancer...
  3. ncbi Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival
    Michelle E Melisko
    Department of Medicine, University of California San Francisco, 1600 Divisadero Street, San Francisco, CA 94115, USA
    J Neurooncol 88:359-65. 2008
    ..As breast cancer patients live longer with control of systemic disease, survival after the diagnosis of brain metastases (BM) also appears to be improving...
  4. ncbi Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers
    Michelle E Melisko
    University of California, San Francisco, USA
    Clin Breast Cancer 6:45-54. 2005
    ..CONCLUSION: Future efforts to improve enrollment should focus on patients' individual concerns and the uneasiness with the randomization...
  5. ncbi Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer
    John W Park
    University of California, San Francisco, San Francisco, CA 94115 1710, USA
    J Clin Oncol 25:3680-7. 2007
    ..We conducted a phase I study to evaluate the safety and immunologic activity of lapuleucel-T in patients with HER-2-overexpressing metastatic breast cancer...
  6. ncbi Amelioration of sexual adverse effects in the early breast cancer patient
    Michelle E Melisko
    Department of Medicine, University of California San Francisco, 94115, USA
    J Cancer Surviv 4:247-55. 2010
    ....
  7. ncbi Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer
    Joseph M Letourneau
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco School of Medicine, San Francisco, California, USA
    Cancer 118:1710-7. 2012
    ..The post-treatment quality of life (QOL) impacts of receiving precancer-treatment infertility counseling and of pursuing fertility preservation have not been described in large-scale studies of reproductive age women with cancer...
  8. ncbi Brain metastases of breast cancer
    Michelle E Melisko
    Division of Hematology Oncology, University of California at San Francisco, San Francisco, CA 94115, USA
    Expert Rev Anticancer Ther 5:253-68. 2005
    ..New approaches include chemotherapy combinations, biologic therapies and novel drug-delivery strategies...